Head-to-head · computed 2026-08-11
Gala GLP-1 vs Willow
Gala GLP-1: Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149. Willow: Willow sells patient-specific 503A compounded tirzepatide at a flat $399 a month at every dose, telehealth and shipping included, in 33 states as of mid-2026 reporting.
Tirzepatide
| Gala GLP-1 | Willow | |
|---|---|---|
| All-in maintenance | $179/mo | $399/mo |
| Best plan rate | $179/mo | $399/mo |
| 12-month total | $2,148 | $4,788 |
| Status | Reported · 2026-07-14 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts Willow's $399 by $220 a month at the 10 mg/wk maintenance basis — $2,640 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and Willow's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Gala GLP-1's tirzepatide ladder runs $179 a month billed monthly, and $199 a month on a three-month plan. Willow's runs $399 a month billed monthly. On the twelve-month basis Gala GLP-1's $2,148 beats Willow's $4,788 by $2,640 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
Only Gala GLP-1 offers semaglutide ($179 a month billed monthly, and $199 a month on a three-month plan); Willow does not, so there is no contest to score.
Where the structures genuinely differ
On verifiability, Gala GLP-1 names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Willow's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice.
Structure, side by side
Gala GLP-1
- MembershipNone
- Dose policyFlat at 'all doses' for standard plan; separate microdosing tier at $149
- Commitment3-month plan or standard monthly; confirm exact terms at enrollment
- CancellationPer provider terms
- PharmacyPartner 503A pharmacies (not named publicly)
Willow
- MembershipNone
- Dose policyDose-flat per captured reporting: flat $399 at every dose
- CommitmentMonthly
- CancellationPer published terms; confirm at checkout
- PharmacyPatient-specific 503A compounding (pharmacy unnamed on captured materials)
What our desk is watching on each
Gala GLP-1: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
Willow: Reported from a June 15, 2026 comparison table (MenoMellow) — our own capture pending; the flat-at-every-dose structure and 33-state footprint both carry that single-source status until independently confirmed. Pharmacy unnamed on captured materials.
Questions people ask
Is Gala GLP-1 or Willow cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Gala GLP-1 vs Willow miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Gala GLP-1 and Willow cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,148 at Gala GLP-1 and $4,788 at Willow — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Gala GLP-1 · Willow. Official sites: Gala GLP-1 ↗ · Willow ↗. Nothing here is medical advice.